Gemcitabine in elderly patients with advanced pancreatic cancer
Author(s) -
Olivia Hentic
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i30.3497
Subject(s) - gemcitabine , medicine , tolerability , neutropenia , chemotherapy , pancreatic cancer , performance status , cancer , oncology , retrospective cohort study , adenocarcinoma , gastroenterology , surgery , adverse effect
To assess feasibility, tolerability and efficacy of gemcitabine-based chemotherapy in patients ≥ 75 years old with advanced pancreatic cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom